Donepezil Treatment in Patients With Depression and Cognitive Impairment on Stable Antidepressant Treatment: A Randomized Controlled Trial

The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

McKhann, G. M., Knopman, D. S., Chertkow, H., Hyman, B. T., Jack, C. R., Kawas, C. H., Klunk, W. E., Koroshetz, W. J., Manly, J. J., Mayeux, R., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.005 · Cited by 18,657 · see citing works

The diagnosis of mild cognitive impairment due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease

Albert, M. S., DeKosky, S. T., Dickson, D., Dubois, B., Feldman, H. H., Fox, N. C., Gamst, A., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2011) · Alzheimer's & Dementia · doi:10.1016/j.jalz.2011.03.008 · Cited by 10,152 · see citing works

Mild cognitive impairment as a diagnostic entity

Petersen, R. C. (2004) · Journal of Internal Medicine · doi:10.1111/j.1365-2796.2004.01388.x · Cited by 7,864 · see citing works

MR signal abnormalities at 1.5 T in Alzheimer's dementia and normal aging

Fazekas, F., Chawluk, J. B., Alavi, A. A., Hurtig, H. I., & Zimmerman, R. A. (1987) · American Journal of Roentgenology · doi:10.2214/ajr.149.2.351 · Cited by 5,327 · see citing works

Measurement of Functional Activities in Older Adults in the Community

PFEFFER, R. I., Kurosaki, T., Harrah, C. H., Chance, J. M., & Filos, S. (1982) · Journal of Gerontology · doi:10.1093/geronj/37.3.323 · Cited by 2,978 · see citing works

The Diagnosis of Mild Cognitive Impairment due to Alzheimer’s Disease: Recommendations from the National Institute on Aging-Alzheimer’s Association Workgroups on Diagnostic Guidelines for Alzheimer’s Disease

Albert, M., DeKosky, S. T., Dickson, D. W., Dubois, B., Feldman, H., Fox, N. C., Gamst, A. C., Holtzman, D. M., Jagust, W. J., Petersen, R. C., et al. (2013) · FOCUS The Journal of Lifelong Learning in Psychiatry · doi:10.1176/appi.focus.11.1.96 · Cited by 2,630 · see citing works

Stereotaxic Display of Brain Lesions

Rorden, C., & Brett, M. (2000) · Behavioural Neurology · doi:10.1155/2000/421719 · Cited by 2,573 · see citing works

Depression in the elderly

Alexopoulos, G. S. (2005) · The Lancet · doi:10.1016/s0140-6736(05)66665-2 · Cited by 2,024 · see citing works

Rating chronic medical illness burden in geropsychiatric practice and research: application of the Cumulative Illness Rating Scale

Miller, M. D., Paradis, C. F., Houck, P. R., Mazumdar, S., Stack, J. A., Rifai, A. H., Mulsant, B., & Reynolds, C. F. (1992) · Psychiatry Research · doi:10.1016/0165-1781(92)90005-n · Cited by 1,990 · see citing works

The Mini-Cog: a cognitive ?vital signs? measure for dementia screening in multi-lingual elderly

Soo Borson, B., Scanlan, J. M., Brush, M. B., VITALIANO, P. P., & Dokmak, A. (2000) · International Journal of Geriatric Psychiatry · doi:10.1002/1099-1166(200011)15:11 · Cited by 1,792 · see citing works

Depression and memory impairment: A meta-analysis of the association, its pattern, and specificity.

Burt, D. B., Zembar, M. J., & Niederehe, G. (1995) · Psychological Bulletin · doi:10.1037/0033-2909.117.2.285 · Cited by 903 · see citing works

Hippocampal and entorhinal atrophy in mild cognitive impairment

Devanand, D. P., Pradhaban, G., Liu, X., Khandji, A., Santi, S. D., Segal, S., Rusinek, H., Pelton, G. H., Honig, L. S., Mayeux, R. P., et al. (2007) · Neurology · doi:10.1212/01.wnl.0000256697.20968.d7 · Cited by 739 · see citing works

The Epidemiology of Depression in an Elderly Community Population

Blazer, D. G., Hughes, D. C., & George, L. K. (1987) · The Gerontologist · doi:10.1093/geront/27.3.281 · Cited by 690 · see citing works

Late-Life Depression, Mild Cognitive Impairment, and Dementia: Possible Continuum?

Panza, F., Frisardi, V., Capurso, C. A., D’Introno, A., Colacicco, A. M., Imbimbo, B. P., Santamato, A., Vendemiale, G., Seripa, D., Pilotto, A., et al. (2010) · American Journal of Geriatric Psychiatry · doi:10.1097/jgp.0b013e3181b0fa13 · Cited by 609 · see citing works

Clinically defined vascular depression

(1997) · American Journal of Psychiatry · doi:10.1176/ajp.154.4.562 · Cited by 557 · see citing works

Depressed Mood and the Incidence of Alzheimer's Disease in the Elderly Living in the Community

Devanand, D. P. (1996) · Archives of General Psychiatry · doi:10.1001/archpsyc.1996.01830020093011 · Cited by 548 · see citing works

Depressive symptoms, cognitive decline, and risk of AD in older persons

Wilson, R. S., Barnes, L. L., Mendes de Leon, C. F., Aggarwal, N. T., Schneider, J. S., Bach, J., Pilat, J., Beckett, L. A., Arnold, S. E., Evans, D. A., et al. (2002) · Neurology · doi:10.1212/wnl.59.3.364 · Cited by 528 · see citing works

Depression and Bipolar Support Alliance consensus statement on the unmet needs in diagnosis and treatment of mood disorders in late life.

Charney, D., Reynolds, C., Lewis, L., Lebowitz, B., Sunderland, T., Alexopoulos, G., Blazer, D., Katz, I., Meyers, B., Areán, P., et al. (2003) · Archives of General Psychiatry · doi:10.1001/archpsyc.60.7.664 · Cited by 485 · see citing works

Association Between Olfactory Dysfunction and Amnestic Mild Cognitive Impairment and Alzheimer Disease Dementia

Roberts, R. O., Christianson, T. J. H., Kremers, W. K., Mielke, M. M., Machulda, M. M., Vassilaki, M. E., Alhurani, R. E., Geda, Y. E., Knopman, D. S., & Petersen, R. C. (2015) · JAMA Neurology · doi:10.1001/jamaneurol.2015.2952 · Cited by 428 · see citing works

Olfactory deficits predict cognitive decline and Alzheimer dementia in an urban community

Devanand, D. P., Lee, S., Manly, J. J., Andrews, H., Schupf, N., Doty, R. L., Stern, Y., Zahodne, L. B., Louis, E. D., & Mayeux, R. P. (2014) · Neurology · doi:10.1212/wnl.0000000000001132 · Cited by 351 · see citing works

Efficacy of donepezil in mild cognitive impairment

Salloway, S., Ferris, S. H., Kluger, A., Goldman, R. S., Griesing, T., Kumar, D., & Richardson, S. (2004) · Neurology · doi:10.1212/01.wnl.0000134664.80320.92 · Cited by 300 · see citing works

Randomized, Placebo-Controlled Trial of the Effects of Donepezil on Neuronal Markers and Hippocampal Volumes in Alzheimer’s Disease

Krishnan, K., Charles, H. C., Doraiswamy, P. M., Mintzer, J. E., Weisler, R. H., Yu, X., Perdomo, C. A., Ieni, J. R., & Rogers, S. L. (2003) · American Journal of Psychiatry · doi:10.1176/appi.ajp.160.11.2003 · Cited by 281 · see citing works

Persistence of cognitive impairment in geriatric patients following antidepressant treatment: a randomized, double-blind clinical trial with nortriptyline and paroxetine

Nebes, R. D., Pollock, B. G., Houck, P. R., Butters, M. A., Mulsant, B. H., Zmuda, M. D., & Reynolds, C. F. (2003) · Journal of Psychiatric Research · doi:10.1016/s0022-3956(02)00085-7 · Cited by 275 · see citing works

Perspectives on Depression, Mild Cognitive Impairment, and Cognitive Decline

Steffens, D. C., Otey, E., Alexopoulos, G. S., Butters, M. A., Cuthbert, B., Ganguli, M., Geda, Y. E., Hendrie, H. C., Krishnan, R. R., Kumar, A., et al. (2006) · Archives of General Psychiatry · doi:10.1001/archpsyc.63.2.130 · Cited by 274 · see citing works

Depressive symptoms increase the risk of progression to dementia in subjects with mild cognitive impairment: systematic review and meta‐analysis

Mourao, R. J., Mansur, G., Malloy‐Diniz, L. F., Costa, E., & Diniz, B. S. (2015) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.4406 · Cited by 258 · see citing works

Clinical characteristics of magnetic resonance imaging-defined subcortical ischemic depression

Krishnan, K., Taylor, W. D., McQuoid, D. R., MacFall, J. R., Payne, M. E., Provenzale, J. M., & Steffens, D. C. (2003) · Biological Psychiatry · doi:10.1016/j.biopsych.2003.08.014 · Cited by 232 · see citing works

A Follow‐Up Study of Age‐Associated Memory Impairment: Neuropsychological Predictors of Dementia

Hänninen, T., Hallikainen, M., Koivisto, K. J., Helkala, E., Reinikainen, K. J., Soininen, H. S., Mykkänen, L. M., Laakso, M., Pyörälà, K., & Riekkinen, P. J. (1995) · Journal of the American Geriatrics Society · doi:10.1111/j.1532-5415.1995.tb05565.x · Cited by 183 · see citing works

Donepezil for vascular cognitive impairment

Malouf, R. S., & Birks, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004395.pub2 · Cited by 182 · see citing works

Maintenance Treatment of Depression in Old Age: A Randomized, Double-blind, Placebo-Controlled Evaluation of the Efficacy and Safety of Donepezil Combined With Antidepressant Pharmacotherapy

Reynolds, C. F., Butters, M. A., Lopez, O., Pollock, B. G., Dew, M. A., Mulsant, B. H., Lenze, E. J., Holm, M., Rogers, J. C., Mazumdar, S., et al. (2011) · Archives of General Psychiatry · doi:10.1001/archgenpsychiatry.2010.184 · Cited by 171 · see citing works

Donepezil delays progression to AD in MCI subjects with depressive symptoms

Lu, P. H., Edland, S. D., Teng, E., Tingus, K., Petersen, R. C., & Cummings, J. L. (2009) · Neurology · doi:10.1212/wnl.0b013e3181aa52d3 · Cited by 150 · see citing works

Sertraline treatment of elderly patients with depression and cognitive impairment

Devanand, D. P., Pelton, G. H., Marston, K., Camacho, Y., Roose, S. P., Stern, Y., & Sackeïm, H. A. (2003) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.802 · Cited by 134 · see citing works

Treatment Course With Antidepressant Therapy in Late-Life Depression

Sheline, Y. I., Disabato, B. M., Hranilovich, J., Morris, C., D’Angelo, G., Pieper, C., Toffanin, T., Taylor, W. D., MacFall, J. R., Wilkins, C., et al. (2012) · American Journal of Psychiatry · doi:10.1176/appi.ajp.2012.12010122 · Cited by 86 · see citing works

Coexistence of lowered mood and cognitive impairment of elderly people in five birth cohorts

Arve, S., Tilvis, R. S., Lehtonen, A., Valvanne, J., & Sairanen, S. (1999) · Aging Clinical and Experimental Research · doi:10.1007/bf03399646 · Cited by 79 · see citing works

Lifetime History of Depression Predicts Increased Amyloid-β Accumulation in Patients with Mild Cognitive Impairment

Chung, J. K., Initiative, A. D. N., Plitman, E., Nakajima, S., Chow, T. W., Chakravarty, M. M., Caravaggio, F., Gerretsen, P., Brown, E. E., Iwata, Y., et al. (2015) · Journal of Alzheimer s Disease · doi:10.3233/jad-142931 · Cited by 65 · see citing works

Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study

Pelton, G. H., Harper, O. L., Tabert, M. H., Sackeïm, H. A., Scarmeas, N., Roose, S. P., & Devanand, D. P. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1958 · Cited by 54 · see citing works

Donepezil for vascular cognitive impairment

Malouf, R. S., & Birks, J. (2003) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd004395 · Cited by 54 · see citing works

A double blind, placebo‐controlled pilot study of galantamine augmentation of antidepressant treatment in older adults with major depression

Holtzheimer, P. E., Meeks, T. W., Kelley, M. E., Mufti, M., Young, R., McWhorter, K., Vito, N., Chismar, R., Quinn, S., Dey, S., et al. (2008) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1951 · Cited by 50 · see citing works

Executive Functioning Complaints and Escitalopram Treatment Response in Late-Life Depression

Manning, K. J., Alexopoulos, G. S., Banerjee, S., Morimoto, S. S., Seirup, J. K., Klimstra, S. A., Yuen, G., Kanellopoulos, T., & Gunning-Dixon, F. (2015) · The American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2013.11.005 · Cited by 49 · see citing works

The external validity of MRI‐defined vascular depression

Pimontel, M. A., Culang‐Reinlieb, M. E., Johnert, L. C., Garcon, E., Sneed, J. R., & Roose, S. P. (2013) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.3943 · Cited by 32 · see citing works

Alzheimer's disease progression model based on integrated biomarkers and clinical measures

Initiative, A. D. N., Qiu, Y., Li, L., Zhou, T., & Lü, W. (2014) · Acta Pharmacologica Sinica · doi:10.1038/aps.2014.57 · Cited by 22 · see citing works

Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): Clinical rationale and design

Pelton, G. H., Andrews, H., Roose, S. P., Marcus, S. M., D’Antonio, K., Husn, H., Petrella, J. R., Zannas, A. S., Doraiswamy, P. M., & Devanand, D. P. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.11.015 · Cited by 18 · see citing works

Olfactory Deficits Predict Cognitive Improvement on Donepezil in Patients With Depression and Cognitive Impairment

Pelton, G. H., Soleimani, L., Roose, S. P., Tabert, M. H., & Devanand, D. P. (2015) · Alzheimer Disease & Associated Disorders · doi:10.1097/wad.0000000000000107 · Cited by 16 · see citing works

Change in Odor Identification Impairment is Associated with Improvement with Cholinesterase Inhibitor Treatment in Mild Cognitive Impairment

Devanand, D. P., Lentz, C. L., Chunga, R. E., Ciarleglio, A., Scodes, J. M., Andrews, H., Schofield, P. W., Stern, Y., Huey, E. D., Bell, K. L., et al. (2017) · Journal of Alzheimer s Disease · doi:10.3233/jad-170497 · Cited by 11 · see citing works

The External Validity of MRI-defined Vascular Depression

Pimontel, M. A., Culang‐Reinlieb, M. E., Johnert, L. C., Garcon, E., Sneed, J. R., & Roose, S. P. (2013) · American Journal of Geriatric Psychiatry · doi:10.1016/j.jagp.2012.12.086 · Cited by 4 · see citing works

Mechanisms and treatment of late-life depression

Alexopoulos, G. S. (2019) · Translational Psychiatry · doi:10.1038/s41398-019-0514-6 · Cited by 592 · see citing works

Acetylcholinesterase Inhibitors in the Treatment of Neurodegenerative Diseases and the Role of Acetylcholinesterase in their Pathogenesis

Walczak, Ł. J., & Herbet, M. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22179290 · Cited by 351 · see citing works

Efficacy and Safety of Cholinesterase Inhibitors for Mild Cognitive Impairment:A Systematic Review and Meta-Analysis

Matsunaga, S., Fujishiro, H., & Takechi, H. (2019) · Journal of Alzheimer s Disease · doi:10.3233/jad-190546 · Cited by 108 · see citing works

Depression in Alzheimer's Disease: A Delphi Consensus on Etiology, Risk Factors, and Clinical Management

Agüera-Ortíz, L., García-Ramos, R., Pérez, F. J. G., López‐Álvarez, J., Rodríguez, J. M. M., Rodríguez, F. J. O., Pueyo, J. O., Valero, C. P., & Porta-Etessam, J. (2021) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2021.638651 · Cited by 83 · see citing works

Pharmacological targeting of cognitive impairment in depression: recent developments and challenges in human clinical research

Colwell, M., Tagomori, H., Chapman, S., Gillespie, A. L., Cowen, P. J., Harmer, C. J., & Murphy, S. E. (2022) · Translational Psychiatry · doi:10.1038/s41398-022-02249-6 · Cited by 63 · see citing works

Efficacy and safety of donepezil for mild cognitive impairment: A systematic review and meta-analysis

Zhang, X., Lian, S., Zhang, Y., & Zhao, Q. (2022) · Clinical Neurology and Neurosurgery · doi:10.1016/j.clineuro.2022.107134 · Cited by 55 · see citing works

Mechanisms of Cognitive Impairment in Depression. May Probiotics Help?

Dobielska, M., Bartosik, N. K., Zyzik, K. A., Kowalczyk, E., & Karbownik, M. S. (2022) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2022.904426 · Cited by 54 · see citing works

Donepezil—an updated review of challenges in dosage form design

Sutthapitaksakul, L., Dass, C. R., & Sriamornsak, P. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102549 · Cited by 46 · see citing works

Electrically controlled drug release of donepezil and BiFeO3 magnetic nanoparticle-loaded PVA microbubbles/nanoparticles for the treatment of Alzheimer's disease

Cesur, S., Çam, M. E., Sayın, F. S., & Gündüz, O. (2021) · Journal of Drug Delivery Science and Technology · doi:10.1016/j.jddst.2021.102977 · Cited by 40 · see citing works

The cholinesterase inhibitor donepezil has antidepressant-like properties in the mouse forced swim test

Fitzgerald, P. J., Hale, P. J., Ghimire, A., & Watson, B. O. (2020) · Translational Psychiatry · doi:10.1038/s41398-020-00928-w · Cited by 35 · see citing works

Depressive disorders in the elderly and dementia: An update

Dias, N. S., Barbosa, I. G., Kuang, W., & Teixeira, A. L. (2020) · Dementia & Neuropsychologia · doi:10.1590/1980-57642020dn14-010001 · Cited by 33 · see citing works

Repurposing Cholinesterase Inhibitors as Antidepressants? Dose and Stress-Sensitivity May Be Critical to Opening Possibilities

Fitzgerald, P. J., Hale, P. J., Ghimire, A., & Watson, B. O. (2021) · Frontiers in Behavioral Neuroscience · doi:10.3389/fnbeh.2020.620119 · Cited by 27 · see citing works

Mechanisms and treatment of late-life depression

Alexopoulos, G. S. (2021) · Focus · doi:10.1176/appi.focus.19304 · Cited by 22 · see citing works

Compared of efficacy and safety of high-dose donepezil vs standard-dose donepezil among elderly patients with Alzheimer’s disease: a systematic review and meta-analysis

Wang, H., Zong, Y., Han, Y., Zhao, J. P., Liu, H., & Liu, Y. (2022) · Expert Opinion on Drug Safety · doi:10.1080/14740338.2022.2027905 · Cited by 21 · see citing works

The efficacy and safety of anti-amyloid monoclonal antibody versus acetylcholinesterase inhibitor with an in-depth analysis across genotypes and disease stages: a systematic review and meta-analysis

Hsu, C., Hsu, T., Kao, Y., Lin, Y., Thompson, T., Carvalho, A. F., Stubbs, B., Tseng, P., Yang, F., Tsai, C., et al. (2025) · The Journal of Prevention of Alzheimer s Disease · doi:10.1016/j.tjpad.2025.100195 · Cited by 20 · see citing works

Factors influencing the deterioration from cognitive decline of normal aging to dementia among nursing home residents

Hayajneh, A. A., Rababa, M., Alghwiri, A. A., & Masha’al, D. (2020) · BMC Geriatrics · doi:10.1186/s12877-020-01875-3 · Cited by 21 · see citing works

Cortical thickness predicts remission of depression with antidepressants in patients with late-life depression and cognitive impairment

Motter, J. N., Lee, S., Sneed, J. R., Doraiswamy, P. M., Pelton, G. H., Petrella, J. R., & Devanand, D. P. (2021) · Journal of Affective Disorders · doi:10.1016/j.jad.2021.08.062 · Cited by 18 · see citing works

Frameworks for estimating causal effects in observational settings: comparing confounder adjustment and instrumental variables

Zawadzki, R. S., Grill, J. D., Gillen, D. L., & Initiative, A. F. T. A. D. N. (2023) · BMC Medical Research Methodology · doi:10.1186/s12874-023-01936-2 · Cited by 19 · see citing works

Efficacy of 5 and 10 mg donepezil in improving cognitive function in patients with dementia: a systematic review and meta-analysis

Sheikh, M., & Ammar, M. (2024) · Frontiers in Neuroscience · doi:10.3389/fnins.2024.1398952 · Cited by 23 · see citing works

Effects of bilateral transcranial direct current stimulation on working memory and global cognition in older patients with remitted major depression: A pilot randomized clinical trial

Kumar, S., Batist, J., Ghazala, Z., Zomorrodi, R., Brooks, H., Goodman, M. S., Blumberger, D. M., Daskalakis, Z. J., Mulsant, B. H., & Rajji, T. K. (2020) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.5361 · Cited by 17 · see citing works

Age at illness onset and physical activity are associated with cognitive impairment in patients with current diagnosis of major depressive disorder

Sánchez‐Carro, Y., Portella, M. J., Leal‐Leturia, I., Salvat‐Pujol, N., Etxandi, M., de Arriba‐Arnau, A., Urretavizcaya, M., Pousa, E., Toll, A., Álvarez, P., et al. (2020) · Journal of Affective Disorders · doi:10.1016/j.jad.2020.10.032 · Cited by 18 · see citing works

General concepts in biostatistics and clinical epidemiology: Experimental studies with randomized clinical trial design

Estrada, S., Marcelo Arancibia, M., Stojanova, J., & Papuzinski, C. (2020) · Medwave · doi:10.5867/medwave.2020.02.7869 · Cited by 17 · see citing works

The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression

Li, X., Li, J., Huang, Y., Gong, Q., Fu, Y., Xu, Y., Huang, J., You, H., Zhang, D., Zhang, D., et al. (2021) · European Journal of Medicinal Chemistry · doi:10.1016/j.ejmech.2021.114045 · Cited by 16 · see citing works

Cholinesterase inhibitors and falls, syncope and injuries in patients with cognitive impairment: a systematic review and meta-analysis

Ahuja, M., Siddhpuria, S., Karimi, A., Lewis, K., Wong, E. K. C., Lee, J., Reppas‐Rindlisbacher, C. E., Sood, E., Gabor, C., & Patterson, C. (2023) · Age and Ageing · doi:10.1093/ageing/afad205 · Cited by 15 · see citing works

Proarrhythmic major adverse cardiac events with donepezil: A systematic review with meta‐analysis

Nham, T., Garcia, M. C., Tsang, K. L. J., Silva, J. M., Schneider, T., Deng, J., Lohit, S., Mbuagbaw, L. C. E., & Holbrook, A. M. (2024) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18909 · Cited by 15 · see citing works

Serum alkaline phosphatase was independently associated with depression in patients with cerebrovascular disease

Tao, X., Chen, Y., He, J., Liu, Q., Wu, S., Tang, W., & Wang, J. (2023) · Frontiers in Psychiatry · doi:10.3389/fpsyt.2023.1184673 · Cited by 12 · see citing works

Late-onset major depressive disorder: exploring the therapeutic potential of enhancing cerebral brain-derived neurotrophic factor expression through targeted microRNA delivery

Lai, G., Malavolta, M., Marcozzi, S., Bigossi, G., Giuliani, M. E., Casoli, T., & Balietti, M. (2024) · Translational Psychiatry · doi:10.1038/s41398-024-02935-7 · Cited by 11 · see citing works

Nanomedicine strategies for central nervous system (CNS) diseases

Nagri, S., Rice, O., & Chen, Y. (2023) · Frontiers in Biomaterials Science · doi:10.3389/fbiom.2023.1215384 · Cited by 9 · see citing works

Recent Advances in Donepezil Delivery Systems via the Nose-to-Brain Pathway

Jon, J., Jeong, J., Jung, J., Cho, H., Song, K., Kim, E., Lee, S. H., Han, E., Chung, W., Moon, A., et al. (2025) · Pharmaceutics · doi:10.3390/pharmaceutics17080958 · Cited by 7 · see citing works

Co-Treatment with the Herbal Medicine SIP3 and Donepezil Improves Memory and Depression in the Mouse Model of Alzheimer’s Disease

Liu, Q. F., Choi, H., Son, T., Kim, Y.-M., Kanmani, S., Chin, Y., Kim, S.-N., Kim, K. K., Kim, K., & Koo, B. (2022) · Current Alzheimer Research · doi:10.2174/1567205019666220413082130 · Cited by 5 · see citing works

Chromone derivatives suppress neuroinflammation and improve mitochondrial function in the sporadic form of Alzheimer's disease under experimental conditions.

Pozdnyakov, D. I., Zolotych, D. S., Rukovitsyna, V. M., & Тоникович, О. Э. (2022) · PubMed Central · doi:10.22038/ijbms.2022.65377.14387 · Cited by 5 · see citing works

Difficult decision‐making in major depressive disorder: Practical guidance based on clinical research and experience

Malhi, G. S., Bell, E., Bassett, D. L., Boyce, P. M., Hopwood, M., Mulder, R., & Porter, R. (2023) · Bipolar Disorders · doi:10.1111/bdi.13350 · Cited by 5 · see citing works

Acetylcholine and Depression: Scrutinizing Future Therapeutic Targets for Novel Drug Development

Pannu, A. S., & Goyal, R. K. (2024) · Current Clinical Pharmacology · doi:10.2174/0127724328311930240907133618 · Cited by 5 · see citing works

Predicting Response to Pro‐Cognitive Interventions in Mood Disorders: A Systematic Review by the International Society for Bipolar Disorders Targeting Cognition Task Force

Tsapekos, D., Kalfas, M., Schandorff, J. M., Bonnín, C. D. M., Bowie, C. R., Balanzá‐Martínez, V., Burdick, K. E., Carvalho, A. F., Dols, A., Douglas, K. M., et al. (2025) · Acta Psychiatrica Scandinavica · doi:10.1111/acps.70038 · Cited by 3 · see citing works

Personalized Prediction of Alzheimer’s Disease and Its Treatment Effects by Donepezil: An Individual Participant Data Meta-Analysis of Eight Randomized Controlled Trials

Yoshida, K., Seo, M., Luo, Y., Sahker, E., Cipriani, A., Leucht, S., Iwatsubo, T., Efthimiou, O., & Furukawa, T. A. (2022) · Journal of Alzheimer s Disease · doi:10.3233/jad-220263 · Cited by 3 · see citing works

Models of depressive pseudoamnestic disorder

Choi, J.-W., Lee, S., Motter, J. N., Kim, H., Andrews, H., Doraiswamy, P. M., Devanand, D. P., & Goldberg, T. E. (2022) · Alzheimer s & Dementia Translational Research & Clinical Interventions · doi:10.1002/trc2.12335 · Cited by 2 · see citing works

Sigma-1-targeting multimodal compound HBK-15 reverses memory deficits and restores hippocampal plasticity under NMDA hypofunction

Sałaciak, K., Lustyk, K., Jagielska, A., Szafarz, M., Inteiro-Oliveira, S., Diógenes, M. J., Xapelli, S., Schnur, P., Morton, L., Moran, E., et al. (2025) · Neurotherapeutics · doi:10.1016/j.neurot.2025.e00774 · Cited by 2 · see citing works

Antidepressant use in dementia: Assessing effective strategies for a vulnerable population

Cozza, M., Fimognari, F. L., Castagna, A., & Boccardi, V. (2025) · Neuroscience & Biobehavioral Reviews · doi:10.1016/j.neubiorev.2025.106340 · Cited by 1 · see citing works

Advancing depression treatment: the role of sigma receptor ligands

Zhang, P., Ning, Z., Chen, H., Chen, J., Lu, Z., & Xu, F. (2025) · Frontiers in Neuroscience · doi:10.3389/fnins.2025.1691987 · Cited by 1 · see citing works

Cumulative cognitive benefits and brain volume change with anti-amyloid therapies for Alzheimer’s disease

Lin, Y., Hsu, T., Kao, Y., Thompson, T., Carvalho, A. F., Stubbs, B., Tseng, P., Hsu, C., Yang, F.-C., Tsai, C., et al. (2026) · Journal of Neurology Neurosurgery & Psychiatry · doi:10.1136/jnnp-2025-336691 · Cited by 1 · see citing works

Treatment of Vascular Cognitive Impairment: A Bibliometric Analysis over a 12-Year Period

(2023) · International Journal of World Medicine · doi:10.38007/ijwm.2023.040207

Theoretical Basis and Application Prospect of Intestinal Flora in the Treatment of Cognitive Dysfunction in Elderly Patients with Depression

陈, 雪. (2023) · Advances in Clinical Medicine · doi:10.12677/acm.2023.13122625

Depression in Dementia

Lee, A. T. C., Mok, V., & LAM, L. C. W. (2024) · Springer eBooks · doi:10.1007/978-981-97-1821-4_6

Factors associated with cognitive function in patient with Alzheimer's disease with newly prescribed acetylcholinesterase inhibitors: A 1‐year retrospective cohort study

Ching, P., Chang, C., Pan, C., Chiang, Y., Kuo, H.-Y., Hsu, T., & Chu, C. (2024) · Aging Medicine · doi:10.1002/agm2.12324

Additional file 1 of Frameworks for estimating causal effects in observational settings: comparing confounder adjustment and instrumental variables

Zawadzki, R. S., Grill, J. D., & Gillen, D. L. (2024) · Figshare · doi:10.6084/m9.figshare.26590760

Additional file 1 of Factors influencing the deterioration from cognitive decline of normal aging to dementia among nursing home residents

Hayajneh, A. A., Rababa, M., Alghwiri, A. A., & Masha’al, D. (2020) · Figshare · doi:10.6084/m9.figshare.13257494

BindingDB Entry 50015325: The novel therapeutic strategy of vilazodone-donepezil chimeras as potent triple-target ligands for the potential treatment of Alzheimer's disease with comorbid depression.

BindingDB (2023) · UC San Diego · doi:10.7270/q29k4g4c

[P4–571]: PLACEBO‐CONTROLLED TRIAL OF DONEPEZIL FOLLOWING ANTIDEPRESSANT TREATMENT IN PATIENTS WITH COMORBID DEPRESSION AND COGNITIVE IMPAIRMENT

Devanand, D. P., Pelton, G. H., Andrews, H., Ciarleglio, A., Scodes, J. M., Petrella, J. R., & Doraiswamy, M. P. (2017) · Alzheimer s & Dementia · doi:10.1016/j.jalz.2017.07.734

Randomized double‐blind placebo‐controlled donepezil augmentation in antidepressant‐treated elderly patients with depression and cognitive impairment: a pilot study

Pelton, G. H., Harper, O. L., Tabert, M. H., Sackeïm, H. A., Scarmeas, N., Roose, S. P., & Devanand, D. P. (2007) · International Journal of Geriatric Psychiatry · doi:10.1002/gps.1958 · Cited by 54 · see citing works

Donepezil treatment of older adults with cognitive impairment and depression (DOTCODE study): Clinical rationale and design

Pelton, G. H., Andrews, H., Roose, S. P., Marcus, S. M., D’Antonio, K., Husn, H., Petrella, J. R., Zannas, A. S., Doraiswamy, P. M., & Devanand, D. P. (2013) · Contemporary Clinical Trials · doi:10.1016/j.cct.2013.11.015 · Cited by 18 · see citing works

Additional donepezil treatment for patients with geriatric depression who exhibit cognitive deficit during treatment for depression

Inoue, J., Hoshino, R., NOJIMA, H., Ishida, W., & Okamoto, N. (2015) · Psychogeriatrics · doi:10.1111/psyg.12121 · Cited by 2 · see citing works

Cholinesterase Inhibitor Adjunctive Therapy for Cognitive Impairment and Depressive Symptoms in Older Adults with Depression

McDermott, C. L., & Gray, S. L. (2012) · Annals of Pharmacotherapy · doi:10.1345/aph.1q445 · Cited by 23 · see citing works